Skip to main content

Rockwell Medical Value Stock - Dividend - Research Selection

Rockwell Medical

ISIN: US7743741024, WKN: 916118

Market price date: 04.06.2021
Market price: 0,91 USD




Rockwell Medical Fundamental data and company key figures of the share

Annual reports in USD
Key figures 02-04-2021
Cash flow
Net operating cash flow -29.641.000
Capital Expenditures -1.046.000
Free cash flow -30.687.000
Balance sheet
Total Equity 34.170.000
Liabilities & Shareholders equity 77.748.000
Income statement
Net income -30.890.000
Eps (diluted) -0,410
Diluted shares outstanding 75.341.500
Net sales/revenue 62.200.000

Fundamental ratios calculated on: 04-06-2021

Ratios
Key figures 04-06-2021
Cash flow
P/C -2,34
   
P/FC -2,23
Balance sheet
ROI-39,73
ROE43,95
Income statement
P/E-2,22
Div. Yield0,00%
P/B2,03
P/S1,10


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolRMTI
Market Capitalization69.314.176,00 USD
Country
IndicesNASDAQ Comp.
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.rockwellmed.com


Description of the company

Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient´s bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.rockwellmed.com